Less Ads, More Data, More Tools Register for FREE

Pin to quick picksZotefoams Plc Regulatory News (ZTF)

Share Price Information for Zotefoams Plc (ZTF)

Share Price is delayed by 15 minutes
Get Live Data
424.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 4.00 (0.939%)
Market Cap: £208.53m
ZTF Live PriceLast checked at - London Stock Exchange

Intraday Zotefoams Plc Share Chart

Third Quarter Trading Update

1 Nov 2017 07:00

RNS Number : 1767V
Zotefoams PLC
01 November 2017
 

Zotefoams plc

("Zotefoams" or the "Company" or "Group")

 

Trading Update

 

1st November 2017 - Zotefoams, a world leader in cellular materials technology, today provides a trading update for the third quarter ended 30 September 2017.

 

Zotefoams is pleased to report continued strong trading during the third quarter, maintaining the momentum of organic sales growth experienced in the first half of the year.

 

· Full year revenues expected to be ahead of market expectations

 

· Adjusted profit before tax and exceptional items for the year ending 31 December 2017 expected to be at the top end of the range of market expectations

 

· Group revenue 22% ahead for the third quarter against the comparative period

 

· Group revenue 24% ahead for the first nine months against the comparative period

 

In constant currency sales grew 16% in the third quarter following a 14% increase for the first six months of the year. The year-to-date growth has been delivered across all business units, with particularly strong growth in High-Performance Products, during the third quarter.

 

Management continues to invest in its strong portfolio of growth prospects and to manage the higher growth rates of early stage opportunities. The order book for the fourth quarter gives confidence that the Company will exceed market expectations for Group revenue and therefore, at current foreign exchange rates, the Board expects adjusted profit before tax and exceptional items for the year ending 31 December 2017 to be at the top end of the range of market expectations.

 

 

 

Commenting on the update David Stirling, Group CEO of Zotefoams, said: 

"We are delighted with the strong organic growth achieved across all business units during the third quarter of 2017. Our ambition is to establish ourselves as the world leader in cellular materials technology in our chosen markets. To achieve this ambition, we are investing significantly in new equipment and enhanced business capability. The Board is confident of another year of positive progress and about the long-term prospects for the business."

 

 

 

- Ends -

 

Enquiries:

 

Zotefoams plc

+44 (0) 208 664 1600

David Stirling, Group CEO

Gary McGrath, Group CFO

IFC Advisory

+44 (0) 203 053 8671

Graham Herring

Miles Nolan

 

About Zotefoams plc

Zotefoams plc (LSE - ZTF) is a world leader in cellular materials technology. Using a unique manufacturing process with environmentally friendly nitrogen expansion, Zotefoams produces and sells lightweight AZOTE® polyolefin and ZOTEK® high-performance foams for diverse markets worldwide. Zotefoams uses its own cellular materials to manufacture T-FIT® advanced insulation for demanding industrial markets. In addition, Zotefoams owns and licenses patented MuCell® microcellular foam technology, developed specifically for extrusion applications, from a base in Massachusetts, USA to customers worldwide.

 

Zotefoams is headquartered in Croydon, UK, with additional manufacturing sites in Kentucky and Oklahoma, USA (foam products manufacture and conversion), Massachusetts, USA (MuCell Extrusion) and Jiangsu Province, China (T-FIT®).

 

www.zotefoams.com

 

AZOTE®, ZOTEK®, T-FIT® are registered trademarks of Zotefoams plc

MuCell® is a registered trademark of Trexel Inc.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUARWRBBAROAA
Date   Source Headline
14th May 20075:55 pmRNSDirectors' Shareholdings
14th May 20073:14 pmRNSResult of AGM
10th May 20077:01 amRNSAGM Statement
19th Apr 20071:47 pmRNSDirector/PDMR Shareholding
13th Apr 20074:31 pmRNSDirector/PDMR Shareholding
12th Apr 20072:34 pmRNSDocuments submission
5th Apr 200712:34 pmRNSBlock Listing Application
20th Mar 20074:18 pmRNSHolding(s) in Company
6th Mar 20077:01 amRNSFinal Results
27th Feb 20072:12 pmRNSHolding(s) in Company
22nd Feb 200710:35 amRNSDirectorate Appointment
18th Dec 20064:58 pmRNSVoting rights & capital
14th Dec 20067:01 amRNSPeriod End Trading Update
5th Dec 20064:50 pmRNSDirector/PDMR Shareholding
17th Nov 20065:00 pmRNSDirector/PDMR Shareholding
13th Oct 20067:00 amRNSDirectorate Change
8th Aug 20067:00 amRNSInterim Results
29th Jun 200611:14 amRNSTrading Statement
15th Jun 20069:56 amRNSBlocklisting Interim Review
23rd May 20062:02 pmRNSResult of AGM
16th May 20067:01 amRNSAGM Statement
11th May 20069:04 amRNSAnnual Information Update
20th Apr 20062:30 pmRNSDirector/PDMR Shareholding
19th Apr 200611:54 amRNSHolding(s) in Company
7th Apr 200612:45 pmRNSAnnual Report and Accounts
30th Mar 20064:14 pmRNSDirectorate Change
29th Mar 200612:27 pmRNSDirector/PDMR Shareholding
29th Mar 200610:49 amRNSDirector/PDMR Shareholding
22nd Mar 20065:14 pmRNSDirector/PDMR Shareholding
21st Mar 20062:37 pmRNSRe Agreement
14th Mar 20067:02 amRNSFinal Results
23rd Dec 200511:24 amRNSDirector/PDMR Shareholding
23rd Dec 200510:19 amRNSDirector/PDMR Shareholding
21st Dec 20055:57 pmRNSHolding(s) in Company
21st Dec 20055:32 pmRNSHolding(s) in Company
15th Dec 20057:00 amRNSPeriod End Trading Update
12th Dec 20054:12 pmRNSBlocklisting Interim Review
22nd Nov 200511:37 amRNSDirector/PDMR Shareholding
2nd Nov 20057:01 amRNSTrading Statement
26th Aug 200512:00 pmRNSUpdate on Directorate
18th Aug 20057:00 amRNSUpdate on Discussions
18th Aug 20057:00 amRNSInterim Results
3rd Aug 200511:23 amRNSRule 8.1- Zotefoams PLC
2nd Aug 200511:14 amRNSRule 8.1- Zotefoams PLC
20th Jul 200511:49 amRNSRule 8.1- Zotefoams PLC
9th Jun 20058:36 amRNSAdditional Listing
3rd May 20055:00 pmRNSHolding(s) in Company
28th Apr 20057:03 amRNSAGM Statement
24th Mar 200511:59 amRNSDocuments on Display
8th Mar 20057:01 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.